Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q4 2022 Earnings

2MarExpected

Q1 2022

Q2 2022

Q3 2022

Q4 2022

-9.25

-6.24

-3.24

-0.23

Details

Expected EPS

-0.2283

Actual EPS

-5

Surprise EPS

-4.77

Surprise Percent

+2,090.1%

Description

Spyre Therapeutics (SYRE) has reported earnings of -5 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.